Tri-modality versus chemoradiation and salvage resection in cN2 stage IIIA Non-Small Cell Lung Cancer

To determine the overall survival (OS) in patients who underwent planned tri-modality therapy (TMT) and those who underwent definitive concurrent chemoradiation (CRT), but later received salvage resection (SR) for stage IIIA (cN2) (AJCC 7th ed.) non-small cell lung cancer (NSCLC).

Source: Seminars in Thoracic and Cardiovascular Surgery - June 16, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Jason C. Ye, Li Ding, Scott M. Atay, Jorge J. Nieva, P. Michael McFadden, Eric Chang, Anthony W. Kim Tags: THORACIC – Original Submission Source Type: research